Quinton (Ding Quan) Ng, PhD, BPharm
he/him/his
Postdoctoral AssociateDownloadHi-Res Photo
Cards
Education
PhD
University of California, Irvine (2025)
University of California, Irvine (2025)
BPharm
National University of Singapore (2019)
National University of Singapore (2019)
Publications Overview
- 37 Publications
- 278 Citations
Featured Publication
Real-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain
Education
PhD
University of California, Irvine (2025)
University of California, Irvine (2025)
BPharm
National University of Singapore (2019)
National University of Singapore (2019)
Publications Overview
- 37 Publications
- 278 Citations
Featured Publication
Real-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain
Education
PhD
University of California, Irvine (2025)
University of California, Irvine (2025)
BPharm
National University of Singapore (2019)
National University of Singapore (2019)
Publications Overview
- 37 Publications
- 278 Citations
Featured Publication
Real-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain
About
Copy Link
Titles
Postdoctoral Associate
Biography
Quinton Ng, PhD, BPharm, is a postdoctoral researcher on the Yale Cancer Center Decision Science Team and Goshua Lab. A pharmacist by training and a pharmacoepidemiologist, he focuses on health outcomes research with a deep commitment to ensuring equitable care across the cancer care continuum. His passion for this work is profoundly personal, stemming from his experience as a caregiver.
His doctoral research at the University of California, Irvine, which earned him the PhRMA Foundation Predoctoral Fellowship, established a novel framework for incorporating integrative oncology therapies into cancer survivorship from an evidence-, science-, and value-based perspective.
At Yale, he continues his research by developing expertise at the intersection of pharmacoepidemiology and decision science. His current work focuses on quantifying the value of new therapies and underutilized interventions in clinical oncology and hematology to inform evidence-based practice, improve patient outcomes, enhance healthcare decision making, and optimize healthcare resource allocation.
Last Updated on October 07, 2025.
Education & Training
- PhD
- University of California, Irvine (2025)
- BPharm
- National University of Singapore (2019)
Research
Copy Link
Overview
Medical Research Interests
Administrative Claims, Healthcare; Biomarkers; Biostatistics; Cancer Survivors; Clinical Trial; Comparative Effectiveness Research; Cost-Effectiveness Analysis; Drug-Related Side Effects and Adverse Reactions; Economics, Medical; Electronic Health Records; Evidence-Based Medicine; Health Equity; Integrative Oncology; Medical Oncology; Pharmacoepidemiology; Survivorship
ORCID
0000-0002-0754-7901
Research at a Glance
Publications Timeline
A big-picture view of Quinton (Ding Quan) Ng's research output by year.
Research Interests
Research topics Quinton (Ding Quan) Ng is interested in exploring.
37Publications
278Citations
Cancer Survivors
Biomarkers
Survivorship
Electronic Health Records
Integrative Oncology
Publications
Featured Publications
Real-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain
Ng D, Lee S, Lee R, Wang Y, Chan A. Real-world impact of acupuncture on analgesics and healthcare resource utilization in breast cancer survivors with pain. BMC Medicine 2024, 22: 394. PMID: 39285302, PMCID: PMC11406884, DOI: 10.1186/s12916-024-03626-2.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsBreast cancer survivorsImpact of acupunctureCancer survivorsHealthcare resource utilizationHealthcare costsAcupuncture-treated patientsHigh-utilizing patientsTotal healthcare costsShort-term opioidsCommercial health insuranceAcupuncture utilizationAcupuncture-treatedPost-acupunctureAcupuncture effectsPrevalence of opioidsMusculoskeletal painAcupunctureCancer diagnosisHealth insuranceReal-world settingsNSAID usePrescription fillsHealthcareUnited StatesResource utilizationBrain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients
Ng D, Cheng I, Wang C, Tan C, Toh Y, Koh Y, Ke Y, Foo K, Chan R, Ho H, Chew L, bin Harunal Rashid M, Chan A. Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients. Scientific Reports 2023, 13: 16298. PMID: 37770565, PMCID: PMC10539508, DOI: 10.1038/s41598-023-43581-1.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCancer-related cognitive impairmentYoung adult cancer patientsBrain-derived neurotrophic factorAdult cancer patientsCambridge Neuropsychological Test Automated BatteryCancer participantsNon-cancer controlsPlasma brain-derived neurotrophic factorSociodemographic variablesBDNF levelsCognitive impairmentBrain-derived neurotrophic factor Val66MetCancer patientsAssociated with worse attentionNeurotrophic factorBrain-derived neurotrophic factor levelsAssociated with enhanced executive functionBaseline BDNF levelsFACT-CogPlasma BDNF levelsPsychological distressImprove cognitive functionBaseline cognitionPost-baselineEnzyme-linked immunosorbent assayImpact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial
Ng D, Tan C, Soh B, Tan M, Loh S, Tan Y, Ong H, Teng P, Chan J, Chay W, Lee J, Lai G, Beh S, Tan T, Yap Y, Lee G, Wong M, Dent R, Lo Y, Chan A, Loh K. Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial. Frontiers In Neurology 2020, 11: 604688. PMID: 33424755, PMCID: PMC7793726, DOI: 10.3389/fneur.2020.604688.Peer-Reviewed Original ResearchCitationsAltmetricConceptsChemotherapy-induced peripheral neuropathyUsual careWeekly paclitaxelPaclitaxel treatmentAutonomic benefitsCycles of weekly paclitaxelPrevent chemotherapy-induced peripheral neuropathyNational Cancer Centre SingaporePatient-reported outcomesEarly breast cancerBreast cancer patientsBenefits of cryotherapyRandomized Controlled TrialsFrozen glovesAutonomic scoreAutonomic neuropathyPrimary endpointImpact of cryotherapyOutcome measuresNo significant differencePost-infusionSensory neuropathyPeripheral neuropathyBreast cancerElectrophysiological assessmentCurrent and recommended practices for evaluating adverse drug events using electronic health records: A systematic review
Ng D, Dang E, Chen L, Nguyen M, Nguyen M, Samman S, Nguyen T, Cadiz C, Nguyen L, Chan A. Current and recommended practices for evaluating adverse drug events using electronic health records: A systematic review. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2021, 4: 1457-1468. DOI: 10.1002/jac5.1524.Peer-Reviewed Original ResearchCitationsAltmetricConceptsElectronic health recordsAdverse drug eventsNewcastle-Ottawa ScaleHealth recordsDrug eventsSystematic reviewAbstract Electronic health recordsModified Newcastle-Ottawa ScaleEvaluate adverse drug eventsStructured EHR dataPeer-reviewed journalsMedian NOS scorePrescribing recordsRecommended practicesEHR dataMethodological qualityIntention-to-treatThematic analysisEffect modifiersDiagnosis codesData synthesisPharmacoepidemiologic researchCohort studyEnd-to-endNOS scoreSubstance Use Among Young Adult Survivors of Childhood Cancer With Cognitive Impairment: An Analysis of the Project Forward Cohort
Ng D, Ritt-Olson A, Freyer D, Miller K, Thomas S, Milam J, Chan A. Substance Use Among Young Adult Survivors of Childhood Cancer With Cognitive Impairment: An Analysis of the Project Forward Cohort. JCO Oncology Practice 2022, 19: e345-e354. PMID: 36508698, PMCID: PMC10022886, DOI: 10.1200/op.22.00458.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsYoung adult childhood cancer survivorsCancer-related cognitive impairmentYoung adult survivors of childhood cancerCancer-related late effectsAdult survivors of childhood cancerAdult childhood cancer survivorsLong-term follow-up clinicSurvivors of childhood cancerChildhood cancer survivorsSubstance use behaviorsYoung adult survivorsLog-binomial regressionMental health issuesSubstance useCognitive impairmentFollow-up clinicLong-term healthAssociated with reportsCancer survivorsUse behaviorsPsychological distressChildhood cancerDepressive symptomsCovariate adjustmentHealth issuesDynamin-1 is a potential mediator in cancer-related cognitive impairment
Ng D, Hudson C, Nguyen T, Gupta S, Koh Y, Acharya M, Chan A. Dynamin-1 is a potential mediator in cancer-related cognitive impairment. Neurotherapeutics 2024, 22: e00480. PMID: 39516074, PMCID: PMC11742811, DOI: 10.1016/j.neurot.2024.e00480.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCancer-related cognitive impairmentFemale mouse modelNon-cancer controlsSpatial recognition memoryConsequences of cancer treatmentYoung adult cancerCytotoxic treatmentControl miceHippocampal CA1Cancer patientsMouse modelSynaptic activityAdult cancersCA3 subregionNeurological consequencesAnimal modelsCognitive impairmentAnimal studiesHuman studiesCancer treatmentNon-cancer participantsTherapeutic targetCancerExposure to cancerChemotherapyUsing machine learning to develop a clinical prediction model for SSRI-associated bleeding: a feasibility study
Goyal J, Ng D, Zhang K, Chan A, Lee J, Zheng K, Hurley-Kim K, Nguyen L, He L, Nguyen M, McBane S, Li W, Cadiz C. Using machine learning to develop a clinical prediction model for SSRI-associated bleeding: a feasibility study. BMC Medical Informatics And Decision Making 2023, 23: 105. PMID: 37301967, PMCID: PMC10257821, DOI: 10.1186/s12911-023-02206-3.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsElectronic health recordsElectronic health record algorithmArea under the receiver operating characteristic curve statisticIntroductionAdverse drug eventsSSRI exposureMedication use informationMachine learningReceiver operating characteristic curve statisticClinically significant featuresNational Institutes of HealthHealth literacyHealth recordsInstitutes of HealthDrug eventsSocioeconomic statusBleeding eventsML modelsDeep learning modelsLogistic regressionSignificant featuresSSRIsClinical prediction modelAssociated with poor outcomesNational InstituteParticipantsImpact of COVID-19 Pandemic on Emergency Department Visits for Opioid Use Disorder Across University of California Health Centers
Heshmatipour M, Ng D, Truong E, Zheng J, Chan A, Wang Y. Impact of COVID-19 Pandemic on Emergency Department Visits for Opioid Use Disorder Across University of California Health Centers. Western Journal Of Emergency Medicine 2024, 0: 883-889. PMID: 39625758, PMCID: PMC11610740, DOI: 10.5811/westjem.18468.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsEmergency department visitsED visit ratesSynthetic opioid overdoseOpioid-related eventsOpioid-related ED visitsED visitsOpioid overdoseElectronic health recordsHealth centersDepartment visitsVisit ratesSynthetic opioidsCOVID-19 pandemicRate ratiosRates of emergency department visitsConfidence intervalsOpioid use disorderNegative binomial regressionPrescription opioid overdoseInternational Classification of DiseasesHealth recordsClinical Modification codesClassification of diseasesAcademic medical centerMonthly visit rates
2025
Brain-derived neurotrophic factor and cytokines as predictors of cognitive impairment in adolescent and young adult cancer patients receiving chemotherapy: a longitudinal study
Trudeau J, Ng D, Sayer M, Tan C, Ke Y, Chan R, Chan A. Brain-derived neurotrophic factor and cytokines as predictors of cognitive impairment in adolescent and young adult cancer patients receiving chemotherapy: a longitudinal study. BMC Cancer 2025, 25: 1045. PMID: 40597835, PMCID: PMC12211463, DOI: 10.1186/s12885-025-14430-3.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsBrain-derived neurotrophic factorNon-cancer controlsCancer-related cognitive impairmentYoung adult cancer patientsAdult cancer patientsCambridge Neuropsychological Test Automated BatteryPost-chemotherapyIL-10TNF-aCancer patientsNeurotrophic factorModulation of brain-derived neurotrophic factorPlasma levels of cytokinesPlasma brain-derived neurotrophic factorBrain-derived neurotrophic factor expressionHigher brain-derived neurotrophic factorAssociated with BDNF levelsLevels of cytokinesAge-matched NCCognitive impairmentTrial registrationThe studyChemotherapy statusDysregulated cytokine signalingPlasma cytokinesIFN-gIncidence and predictors of immune checkpoint inhibitor treatment–related cognitive impairment in a racial and ethnic diverse population
Sayer M, Agrawal P, Ng D, Kagramanov D, Trudeau J, Othy S, Acharya M, Chan A. Incidence and predictors of immune checkpoint inhibitor treatment–related cognitive impairment in a racial and ethnic diverse population. Supportive Care In Cancer 2025, 33: 523. PMID: 40451933, PMCID: PMC12127230, DOI: 10.1007/s00520-025-09560-0.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsIntroductionImmune checkpoint inhibitorsTherapy initiationPatient-reported outcomesGeneralized Estimating EquationsSignificant cognitive impairmentICI-treated patientsAnti-cancer immunityClinically significant cognitive impairmentCognitive functionCognitive impairmentTreatment-related cognitive impairmentPhysical functionCheckpoint inhibitorsMild to severe symptomsImpaired physical functionRisk patientsImmune dysregulationConcurrent symptomsInflammatory biomarkersPatient characteristicsSymptom scoresCancer therapyCognitive function scoresT-scoreTherapy
Academic Achievements & Community Involvement
Copy Link
Honors
honor Predoctoral Fellowship in Value Assessment and Health Outcomes Research
04/13/2023National AwardPhRMA FoundationDetailsUnited States
Links
Copy Link
Get In Touch
Copy Link
Contacts
Email
Locations
Yale Cancer Center Decision Science
Academic Office
300 George Street, Ste 900
New Haven, CT 06511
Social Media